The Center for Biomedical Technology has successfully developed extracorporeal liver support technologies. In this project new targets for extracorporeal liver support will be investigated. A spectrum of bile acids will be tested for their depletion from blood using adsorbent-based apheresis systems. Additionally, the influence of liver support systems on human serum albumins (HSA) regarding oxidized HSA-fractions and changes in albumin conformation will be evaluated. Furthermore, it will be tested whether the quantitative change of oxidized HSA can be used as biomarker to optimize treatment time in extracorporeal liver support.

Country of Lower Austria, EFRE
Fresenius Medical Care        






Duration 01/01/2016 - 31/12/2019
Funding Bundesländer (inkl. deren Stiftungen und Einrichtungen)
Program Technologieförderung NÖ

Department for Biomedical Research

Center for Biomedical Technology

Principle investigator for the project (Danube University Krems) Ass. Prof. Dr. Jens Hartmann

Project Manager

Back to top


To Glossary

This website uses cookies to improve your user experience and for analytical purposes for optimizing our systems, as well Google Maps for the use of depicting maps. By clicking on „OK" or continuing to browse the site, you are agreeing to the use of cookies and Google Maps. More information concerning privacy policy and data protection official.